• Caspase-3 Cleavage of NDUFS1 Drives Mitochondrial ROS in Tri

  2026-05-03

  This study reveals that trichothecene mycotoxins induce mitochondrial dysfunction and ROS accumulation in liver by activating caspase-3, which cleaves NDUFS1, a core subunit of mitochondrial complex I. The work further identifies ER-localized ERO1α as a parallel, non-mitochondrial contributor to oxidative stress, clarifying mechanisms of mycotoxin-induced hepatotoxicity and highlighting molecular targets for intervention.

• Dual-Action Kinase Inhibitors Modulate p38α MAPK Dephosphory

  2026-05-02

  This study reveals that certain kinase inhibitors, beyond blocking catalytic activity, can promote dephosphorylation of the p38α MAP kinase by stabilizing conformations accessible to phosphatases. The findings suggest a new paradigm for rationally designing kinase inhibitors with enhanced specificity and dual functional profiles.

• Caspase-6 Cleavage of PRRSV N Protein Drives Immune Evasion

  2026-05-02

  This study uncovers a novel mechanism by which porcine reproductive and respiratory syndrome virus (PRRSV) exploits host caspase-6 to cleave its nucleocapsid (N) protein, suppressing interferon signaling and promoting viral replication. The findings highlight the conserved D94 cleavage site as a potential target for antiviral strategies and rational vaccine design.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Resea

  2026-05-01

  TAK-715 stands out as a highly selective p38 MAPK inhibitor, enabling researchers to dissect cytokine signaling and inflammation with nanomolar precision. Its unique dual-action mechanism, which enhances both kinase inhibition and phosphatase-driven deactivation, streamlines experimental workflows and advances chronic inflammatory disease models.

• Innovations in FITC Goat Anti-Mouse IgG (H+L) Antibody for N

  2026-04-30

  Discover the advanced capabilities of the FITC Goat Anti-Mouse IgG (H+L) Antibody in high-sensitivity immunofluorescence and flow cytometry. This article explores its unique mechanism, scientific innovations, and practical implications for assay optimization.

• Deferasirox: Oral Iron Chelator Transforming Experimental On

  2026-04-30

  Deferasirox, a trivalent oral iron chelator, enables precision modulation of iron metabolism in oncology and hematology research. Explore how its unique mechanistic profile and robust workflow compatibility drive reproducible outcomes in cancer, iron overload, and cell death studies.

• Puerarin Promotes Osteogenic Differentiation via NO Pathway

  2026-04-29

  This study reveals that puerarin enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide (NO) pathway. The findings clarify the mechanistic role of NO signaling in periodontal regeneration and underscore the utility of NOS inhibitors like L-NMMA acetate for dissecting pathway-specific effects.

• Ciprofloxacin in Research: Precision Tools for Modeling Resi

  2026-04-29

  Explore the multifaceted role of ciprofloxacin, a key fluoroquinolone antibiotic, in antimicrobial resistance research. This article offers original insights on protocol design, genetic transmission dynamics, and advanced assay considerations, setting it apart from standard product guides.

• cgSHAPE-seq Maps RNA-Degrader Binding Sites in SARS-CoV-2 5′

  2026-04-28

  This study introduces cgSHAPE-seq, a chemical-guided sequencing approach for pinpointing small molecule binding sites on structured viral RNA, exemplified by the SARS-CoV-2 5′ UTR. The method enables rational design of RNA-degrading chimeras, advancing strategies for antiviral intervention.

• Scenario-Based Solutions with DiscoveryProbe™ Protease Inhib

  2026-04-28

  This article explores how the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays. By grounding evidence in published research and validated product data, we demonstrate the library’s value in enhancing assay reliability, sensitivity, and workflow integration for biomedical researchers.

• Co-Targeting BRD4 and RAC1 Disrupts Oncogenic Axes in Breast

  2026-04-27

  The referenced study demonstrates that simultaneous inhibition of BET bromodomain BRD4 and RAC1 in diverse breast cancer subtypes disrupts the c-MYC-G9a-FTH1 axis and downregulates HDAC1, suppressing tumor growth and stemness. These findings highlight the importance of combinatorial epigenetic targeting for cancer therapy and provide mechanistic insights into chromatin remodeling as a therapeutic strategy.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist in Rese

  2026-04-27

  G-15 is a highly selective G protein-coupled estrogen receptor antagonist, enabling unprecedented specificity in dissecting GPR30-mediated signaling without disrupting classical estrogen receptor pathways. This article details rigorous experimental workflows, practical optimization, and troubleshooting insights for leveraging G-15 in advanced estrogen signaling research and immunological models.

• Distinct Cell Death Pathways in ALL Cells After Microtubule

  2026-04-26

  This study demonstrates that primary acute lymphoblastic leukemia (ALL) cells undergo different cell death mechanisms depending on their cell cycle phase when exposed to microtubule depolymerizing agents. The findings clarify the phase-specific molecular processes underlying MTA sensitivity and highlight the complexity of cell death responses in cancer chemotherapy.

• CUDC-907: Dual PI3K and HDAC Inhibitor Protocol Guidance

  2026-04-25

  CUDC-907 provides researchers with a practical tool for dual inhibition of PI3K and HDAC signaling in cancer cell models. It enables precise modulation of the PI3K/AKT pathway and histone deacetylation in established in vitro workflows. This compound is not suitable for diagnostic or clinical applications and should only be used as directed in controlled research settings.

• T7 RNA Polymerase (SKU K1083): Reliable RNA Synthesis for As

  2026-04-24

  This article explores real-world challenges in RNA synthesis workflows and demonstrates how T7 RNA Polymerase (SKU K1083), a recombinant enzyme expressed in E. coli, supports reliable, high-fidelity in vitro transcription for biomedical researchers. Scenario-driven Q&A blocks provide actionable insights, protocol parameters, and candid product selection guidance rooted in peer-reviewed evidence and laboratory best practices.

459 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page